Maurizio PetitBon
Presidente presso TME PHARMA N.V.
Provenienza dei contatti di primo grado di Maurizio PetitBon
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Kreos Capital Management (UK) Ltd.
 Kreos Capital Management (UK) Ltd. Investment ManagersFinance Kreos Capital Management (UK) Ltd (Kreos Capital) is a private equity firm founded in 1998. The firm is headquartered in London with additional offices in Israel, Sweden, Jersey and Luxembourg.
40
| Subsidiary | Investment Managers | 40 |
| Public Company | Biotechnology | 16 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Maurizio PetitBon tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin | |
Theta Microelectronics, Inc.
 Theta Microelectronics, Inc. SemiconductorsElectronic Technology Theta Microelectronics, Inc. provides radio frequency integrated circuits design services. It provides radio frequency integrated circuits for mobile and fixed wireless connectivity and video applications. The firm serves the mobile computing, imaging, multimedia, and communications markets. The company was founded by Yannis Tsividis and Yannis Papananos in 1994 and is headquartered in Coppell, TX. | Semiconductors | Director/Board Member | |
Financial Payment Systems Ltd.
 Financial Payment Systems Ltd. Regional BanksFinance The Group's principal activity is developing, integrating and managing an electronic payment approval and authorisation system. The Group has full intellectual property ownership rights to certain software technology developed specifically for the installation, implementation and operation of such systems. It has a joint venture with Jiangsu Electronic Business Co Ltd, which is partly state-owned and numbers China Telecom among its shareholders, for payment infrastructure modernization within Jiangsu province. The joint venture was established to roll out and promote a financial payment authorization system to government departments as well as the integrating the system to the banks to allow payment settlements to be made. It specialises in the delivery of electronic payment services, to be set as an industry standard payment infrastructure, with its own product called EnterBanking. | Regional Banks | Chairman | |
| HUNTER RESOURCES PLC | Precious Metals | Director/Board Member | |
EPIX Therapeutics, Inc.
 EPIX Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology EPIX Therapeutics, Inc. operates as a medical device company that designs and manufactures catheter-based systems. It offers irrigated radiofrequency ablation catheters for atrial fibrillation. The company was founded by Kenneth Carr, Peter van der Sluis, Eric Kanowsky and Timothy J. Lenihan in 2007 and is headquartered in Santa Clara, CA. | Electronic Equipment/Instruments | Director/Board Member | |
| EVOTEC SE | Pharmaceuticals: Major | Chairman Director/Board Member | |
| NORTHACRE PLC | Real Estate Development | Director/Board Member | |
Strathdon Investments Ltd.
 Strathdon Investments Ltd. Investment ManagersFinance Strathdon Investments Ltd. invests in companies located in the United Kingdom. The fund targets companies operating in the fields of information technology, energy, finance, healthcare and process control sectors. It provides financing for startups and buyout capital with an investment size £50K and £2m. | Investment Managers | Director/Board Member | |
Takeda Corp.
 Takeda Corp. Pharmaceuticals: MajorHealth Technology Takeda Corp. manufactures and distributes pharmaceutical products. The company is headquartered in Tokyo, Japan | Pharmaceuticals: Major | Corporate Officer/Principal | |
Dresdner Kleinwort Capital, Inc.
 Dresdner Kleinwort Capital, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Niederösterreichische GmbH, Dresdner Kleinwort Capital, Inc. is a company that provides financial services. The company is based in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| Brigham Young University | College/University | Undergraduate Degree | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| University of Utrecht | College/University | Doctorate Degree Doctorate Degree | |
| University of Surrey | College/University | Undergraduate Degree Undergraduate Degree | |
Gutmann /Private Equity/
 Gutmann /Private Equity/ Investment ManagersFinance Gutmann KAG /Private Equity/ is an operational private equity division of Gutmann KAG with headquarters in Vienna, Austria. Gutmann KAG /Private Equity/ was founded in 1986. | Investment Managers | Chief Operating Officer | |
| SYMETIS SA | Biotechnology | Director/Board Member | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Graduate Degree | |
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Investment Banks/Brokers | Analyst-Equity | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
Upfront Chromatography A/S
 Upfront Chromatography A/S Miscellaneous Commercial ServicesCommercial Services Upfront Chromatography A/S develops a customized protein separation process. The firm offers industrial-scale customized separation solutions to isolate and purify soluble proteins from industrial process streams. Its core protein purification technology, rhobust, is applicable to industrial feed stocks. The company was founded by Allan Otto Fog Lihme in 1992 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
| European Venture Partners (GP) Ltd. | Director/Board Member | ||
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
Global Finance Group
 Global Finance Group Finance/Rental/LeasingFinance Global Finance Group provides equipment financing services. The private company is based in Newport Beach, CA. | Finance/Rental/Leasing | Chief Operating Officer | |
Quanta Dialysis Technologies Ltd.
 Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Quanta Dialysis Technologies Ltd. develops haemodialysis systems. The firm's SC+ is a performance, portable, compact haemodialysis system providing clinical efficacy utilising flow rates typically used on traditional machines. It offers SelfCare+, a haemodialysis machine for dialysis patients to control their disease and determine the treatment regime and care. The company was founded by Clive Henrey Buckberry, John Eric Milad and Martin Johnson in 2008 and is headquartered in Alcester, the United Kingdom. | Medical Specialties | Director/Board Member | |
| Pfizer NV/SA | Corporate Officer/Principal | ||
GATX Ventures, Inc.
 GATX Ventures, Inc. Investment ManagersFinance GATX Ventures, Inc. (GATX Ventures Inc), a subsidiary of GATX Financial Corp. is a venture capital firm founded in 1999. The firm is headquartered in Chicago, Illinois. | Investment Managers | Private Equity Investor | |
| ISOFOL MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Global Private Equity | Chief Operating Officer | ||
| Mesothelioma Applied Research Foundation, Inc. | Director/Board Member | ||
| Kleinwort Benson (Hong Kong) Ltd. | President | ||
| Kleinwort Benson (Deutschland) GmbH | Corporate Officer/Principal | ||
| Emminol Ltd. | Director/Board Member | ||
| Marshalsea Road Management | Director/Board Member | ||
| The University of Texas School of Law | College/University | Undergraduate Degree | |
| SDA Bocconi School of Management | College/University | Undergraduate Degree | |
Scenic Biotech BV
 Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Chief Executive Officer | |
| MINERALYS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Escp Business School | College/University | Undergraduate Degree Undergraduate Degree | |
Alma I Advisory Ltd.
 Alma I Advisory Ltd. Investment ManagersFinance Alma I Advisory Ltd (Atempo Growth) is a venture capital firm founded in 2021 by Luca Colciago, Matteo Avramov Giulivi and Jack Diamond. The firm is headquartered in London. | Investment Managers | Founder Founder Founder | |
Ariceum Therapeutics GmbH
 Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| CELLNOVO | Medical Specialties | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 14 |
| Regno Unito | 11 |
| Germania | 8 |
| Francia | 8 |
| Paesi Bassi | 4 |
Settori
| Health Technology | 17 |
| Consumer Services | 11 |
| Finance | 9 |
| Commercial Services | 5 |
| Electronic Technology | 4 |
Posizioni
| Director/Board Member | 127 |
| Chairman | 34 |
| Corporate Officer/Principal | 29 |
| Private Equity Analyst | 28 |
| Director of Finance/CFO | 27 |
Contatti più connessi
| Insiders | |
|---|---|
| Joseph deBethizy | 29 |
| Hubert Birner | 27 |
| Gregory Weaver | 22 |
| Olivier Litzka | 21 |
| Geoff Woolley | 19 |
| Aris Constantinides | 19 |
| Jarl Ulf Birger Jungnelius | 16 |
| Walter Wenninger | 14 |
| Bertram Köhler | 13 |
| Malcolm Francis Williams | 13 |
| Aram Andrew Mangasarian | 11 |
| Bryan Jennings | 10 |
| Susan Coles | 10 |
| Martine van Vugt | 7 |
| Matthias Baumann | 7 |
- Borsa valori
- Insiders
- Maurizio PetitBon
- Connessioni Società
